These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 9407957

  • 1. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer.
    Lavigne JA, Helzlsouer KJ, Huang HY, Strickland PT, Bell DA, Selmin O, Watson MA, Hoffman S, Comstock GW, Yager JD.
    Cancer Res; 1997 Dec 15; 57(24):5493-7. PubMed ID: 9407957
    [Abstract] [Full Text] [Related]

  • 2. Genetic susceptibility of catechol-O-methyltransferase polymorphism in Japanese patients with breast cancer.
    Inoue H, Shibuta K, Matsuyama A, Yoshinaga K, Sadanaga N, Ueo H, Barnard GF, Mori M.
    Oncol Rep; 2005 Sep 15; 14(3):707-12. PubMed ID: 16077979
    [Abstract] [Full Text] [Related]

  • 3. Polymorphic catechol-O-methyltransferase gene and breast cancer risk.
    Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma VM, Benhamou S, Kang D, Vainio H, Uusitupa M, Hirvonen A.
    Cancer Epidemiol Biomarkers Prev; 2001 Jun 15; 10(6):635-40. PubMed ID: 11401913
    [Abstract] [Full Text] [Related]

  • 4. Combined effect of GSTM1, GSTT1, and COMT genotypes in individual breast cancer risk.
    Park SK, Yim DS, Yoon KS, Choi IM, Choi JY, Yoo KY, Noh DY, Choe KJ, Ahn SH, Hirvonen A, Kang D.
    Breast Cancer Res Treat; 2004 Nov 15; 88(1):55-62. PubMed ID: 15538046
    [Abstract] [Full Text] [Related]

  • 5. Val158Met Polymorphism in catechol-O-methyltransferase gene associated with risk factors for breast cancer.
    Hong CC, Thompson HJ, Jiang C, Hammond GL, Tritchler D, Yaffe M, Boyd NF.
    Cancer Epidemiol Biomarkers Prev; 2003 Sep 15; 12(9):838-47. PubMed ID: 14504192
    [Abstract] [Full Text] [Related]

  • 6. Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk.
    Thompson PA, Shields PG, Freudenheim JL, Stone A, Vena JE, Marshall JR, Graham S, Laughlin R, Nemoto T, Kadlubar FF, Ambrosone CB.
    Cancer Res; 1998 May 15; 58(10):2107-10. PubMed ID: 9605753
    [Abstract] [Full Text] [Related]

  • 7. Catechol-O-methyltransferase polymorphism is not associated with ovarian cancer risk.
    Goodman JE, Lavigne JA, Hengstler JG, Tanner B, Helzlsouer KJ, Yager JD.
    Cancer Epidemiol Biomarkers Prev; 2000 Dec 15; 9(12):1373-6. PubMed ID: 11142424
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V, Rastogi N, Sinha A, Kumar A, Mathur N, Singh MP.
    Breast Cancer Res Treat; 2007 Jan 15; 101(1):73-81. PubMed ID: 16807674
    [Abstract] [Full Text] [Related]

  • 11. [Polymorphism of catechol-O-methyltransferase gene in relation to the risk of endometrial cancer].
    Zhao XM, Xie MQ, Yang DZ, Wang LA, Li SJ, Zhuang YY, Tang XL.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Feb 15; 42(2):116-9. PubMed ID: 17442187
    [Abstract] [Full Text] [Related]

  • 12. Catechol-O-methyltransferase Val 108/158 Met polymorphism in premenopausal breast cancer patients.
    Sazci A, Ergul E, Utkan NZ, Canturk NZ, Kaya G.
    Toxicology; 2004 Nov 15; 204(2-3):197-202. PubMed ID: 15388245
    [Abstract] [Full Text] [Related]

  • 13. [Relation between single nucleotide polymorphism in estrogen-metabolizing genes COMT, CYP17 and breast cancer risk among Chinese women].
    Tan W, Qi J, Xing DY, Miao XP, Pan KF, Zhang L, Lin DX.
    Zhonghua Zhong Liu Za Zhi; 2003 Sep 15; 25(5):453-6. PubMed ID: 14575568
    [Abstract] [Full Text] [Related]

  • 14. Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms.
    Dawling S, Roodi N, Mernaugh RL, Wang X, Parl FF.
    Cancer Res; 2001 Sep 15; 61(18):6716-22. PubMed ID: 11559542
    [Abstract] [Full Text] [Related]

  • 15. [Prevalence of Val158Met polymorphism in COMT gene on non-BRCA1/2 hereditary breast cancer].
    Song CG, Hu Z, Yuan WT, Di GH, Shen ZZ, Huang W, Shao ZM.
    Zhonghua Wai Ke Za Zhi; 2006 Oct 01; 44(19):1310-3. PubMed ID: 17217814
    [Abstract] [Full Text] [Related]

  • 16. Equine catechol estrogen 4-hydroxyequilenin is a more potent inhibitor of the variant form of catechol-O-methyltransferase.
    Li Y, Yao J, Chang M, Nikolic D, Yu L, Yager JD, Mesecar AD, van Breemen RB, Bolton JL.
    Chem Res Toxicol; 2004 Apr 01; 17(4):512-20. PubMed ID: 15089093
    [Abstract] [Full Text] [Related]

  • 17. Estrogens metabolism associated with polymorphisms: influence of COMT G482a genotype on age at onset of canine mammary tumors.
    Dias Pereira P, Lopes CC, Matos AJ, Pinto D, Gärtner F, Lopes C, Medeiros R.
    Vet Pathol; 2008 Mar 01; 45(2):124-30. PubMed ID: 18424824
    [Abstract] [Full Text] [Related]

  • 18. Genetic polymorphism of manganese superoxide dismutase (MnSOD) and breast cancer susceptibility.
    Kocabaş NA, Sardaş S, Cholerton S, Daly AK, Elhan AH, Karakaya AE.
    Cell Biochem Funct; 2005 Mar 01; 23(1):73-6. PubMed ID: 15386537
    [Abstract] [Full Text] [Related]

  • 19. Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer.
    Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma VM, Benhamou S, Vainio H, Uusitupa M, Hirvonen A.
    Cancer Epidemiol Biomarkers Prev; 2001 Mar 01; 10(3):229-36. PubMed ID: 11303592
    [Abstract] [Full Text] [Related]

  • 20. The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells.
    Lavigne JA, Goodman JE, Fonong T, Odwin S, He P, Roberts DW, Yager JD.
    Cancer Res; 2001 Oct 15; 61(20):7488-94. PubMed ID: 11606384
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.